Isolated neurosarcoidosis: Case series in 2 sarcoidosis centers

Neurologist

Volumn 18, Issue 6, 2012, Pages 373-377

  Nozaki, Kenkichi ^a   Scott, Thomas F ^b   Sohn, Mimi ^a   Judson, Marc A ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

biopsy; case series; diagnosis; neurosarcoidosis

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BRAIN BIOPSY; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; CRANIAL NEUROPATHY; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HEADACHE; HEMIPARESIS; HUMAN; HUMAN TISSUE; ISOLATED NEUROSARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PRIORITY JOURNAL; PROGNOSIS; RADICULOPATHY; RETROSPECTIVE STUDY; SARCOIDOSIS; TREATMENT OUTCOME;

ADULT; AGE OF ONSET; AGED; BIOPSY; CENTRAL NERVOUS SYSTEM DISEASES; CRANIAL NERVE DISEASES; FEMALE; HEADACHE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 84869756729     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e3182704d04     Document Type: Article

References (37)

1. Judson MA. Sarcoidosis: Clinical presentation, diagnosis, and approach to treatment. Am J Med Sci. 2008;335:26-33.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee February 1999. Am J Respir Crit Care Med. 1999;160:736-755.
3. Terushkin V, Stern BJ, Judson MA, et al. Neurosarcoidosis: Presentations and management. Neurologist. 2010;16:2-15.
4. Chen RC, McLeod JG. Neurological complications of sarcoidosis. Clin Exp Neurol. 1989;26:99-112.
5. Stern BJ, Krumholz A, Johns C, et al. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909-917.
6. Delaney P. Neurologic manifestations in sarcoidosis: Review of the literature, with a report of 23 cases. Ann Intern Med. 1977; 87:336-345.
7. Lower EE, Broderick JP, Brott TG, et al. Diagnosis and management of neurological sarcoidosis. Arch Intern Med. 1997; 157:1864-1868.
8. Scott TF. Neurosarcoidosis: Progress and clinical aspects. Neurology. 1993;43:8-12.
9. Scott TF, Yandora K, Valeri A, et al. Aggressive therapy for neurosarcoidosis: Long-Term follow-Up of 48 treated patients. Arch Neurol. 2007;64:691-696.
10. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
11. Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: The ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:75-86.
12. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis - Diagnosis and management. QJM. 1999;92: 103-117.
13. Ahn SW, Kim KT, Youn YC, et al. Isolated spinal cord neurosarcoidosis diagnosed by cord biopsy and thalidomide trial. J Korean Med Sci. 2011;26:154-157.
14. Duhon BS, Shah L, Schmidt MH. Isolated intramedullary neurosarcoidosis of the thoracic spine: Case report and review of the literature. Eur Spine J. 2012;21(SUPPL4):S390-S395.
15. Mariani M, Shammi P. Neurosarcoidosis and associated neuropsychological sequelae: A rare case of isolated intracranial involvement. Clin Neuropsychol. 2010;24:286-304.
16. Oh J, Stokes K, Tyndel F, et al. Progressive cognitive decline in a patient with isolated chronic neurosarcoidosis. Neurologist. 2010;16:50-53.
17. Pillai P, Ray-Chaudhury A, Ammirati M, et al. Solitary pituitary sarcoidosis with normal endocrine function: Case report. J Neurosurg. 2008;108:591-594.
18. Terada T, Shigeno K, Hori M, et al. Isolated spinal neurosarcoidosis: An autopsy case. Spinal Cord. 2010;48:776-778.
19. Bode MK, Tikkakoski T, Tuisku S, et al. Isolated neurosarcoidosis - MR findings and pathologic correlation. Acta Radiol. 2001;42:563-567.
20. Brinar VV, Habek M. Isolated central nervous system sarcoidosis: A great mimicker. Clin Neurol Neurosurg. 2008;110:939-942.
21. Mayer SA, Yim GK, Onesti ST, et al. Biopsy-proven isolated sarcoid meningitis. Case report. J Neurosurg. 1993;78:994-996.
22. Rudkin AK, Wilcox RA, Slee M, et al. Relapsing encephalopathy with headache: An unusual presentation of isolated intracranial neurosarcoidosis. J Neurol Neurosurg Psychiatry. 2007;78: 770-771.
23. Tsao CY, Lo WD, Rusin JA, et al. Isolated neurosarcoidosis presenting as headache and multiple brain and spinal cord lesions mimicking central nervous system metastases. Brain Dev. 2007; 29:514-518.
24. Uchino M, Nagao T, Harada N, et al. Neurosarcoidosis without systemic sarcoidosis - Case report. Neurol Med Chir (Tokyo). 2001;41:48-51.
25. Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. AJR. 2004;182:289-295.
26. Judson MA. The diagnosis of sarcoidosis. Clin Chest Med. 2008;29:415-427, viii
27. Mana J. Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med. 1997;18:799-811.
28. Teirstein AS, Machac J, Almeida O, et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007;132: 1949-1953.
29. Sharma OP. Neurosarcoidosis: A personal perspective based on the study of 37 patients. Chest. 1997;112:220-228.
30. Khoury J, Wellik KE, Demaerschalk BM, et al. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist. 2009;15:108-111.
31. Dale JC, O'Brien JF. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc. 1999;74:535.
32. Tahmoush AJ, Amir MS, Connor WW, et al. CSF-ACE activity in probable CNS neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:191-197.
33. Ferriby D, de Seze J, Stojkovic T, et al. Long-Term follow-Up of neurosarcoidosis. Neurology. 2001;57:927-929.
34. Joseph FG, Scolding NJ. Neurosarcoidosis: A study of 30 new cases. J Neurol Neurosurg Psychiatry. 2009;80:297-304.
35. Christoforidis GA, Spickler EM, Recio MV, et al. MR of CNS sarcoidosis: Correlation of imaging features to clinical symptoms and response to treatment. AJNR. 1999;20:655-669.
36. Shah R, Roberson GH, Cure JK. Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis. AJNR. 2009;30:953-961.
37. Spencer TS, Campellone JV, Maldonado I, et al. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum. 2005;34:649-661.